Eman Z. Elrazaz

Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents

Eman Z. Elrazaz, Rabah A.T. Serya, Nasser S. M. Ismail et al. · Future Journal of Pharmaceutical Sciences · 2015 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, synthesis and<i>in silico</i>studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors

Sayed K. Ramadan, Eman Z. Elrazaz, Khaled A. M. Abouzid et al. · RSC Advances · 2020 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors

Soha R. Abd El Hadi, Deena S. Lasheen, Dalia H. Soliman et al. · Bioorganic Chemistry · 2020 · 42 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations

Eman Z. Elrazaz, Rabah A.T. Serya, Nasser S. M. Ismail et al. · Bioorganic Chemistry · 2021 · 41 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of pyrano[2,3-<i>d</i>]pyrimidine-2,4-dione derivatives as novel PARP-1 inhibitors: design, synthesis and antitumor activity

Nour E. A. Abd El‐Sattar, Eman H. K. Badawy, Eman Z. Elrazaz et al. · RSC Advances · 2021 · 32 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16